• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . Functional and antigenic characterization of SARS-CoV-2 spike fusion peptide by deep mutational scanning

tetano

Editor, Senior Moderator
Nat Commun


. 2024 May 14;15(1):4056.
doi: 10.1038/s41467-024-48104-8. Functional and antigenic characterization of SARS-CoV-2 spike fusion peptide by deep mutational scanning

Ruipeng Lei[SUP] #[/SUP][SUP] 1 [/SUP], Enya Qing[SUP] #[/SUP][SUP] 2 [/SUP], Abby Odle[SUP] 3 [/SUP], Meng Yuan[SUP] 4 [/SUP], Chaminda D Gunawardene[SUP] 5 6 [/SUP], Timothy J C Tan[SUP] 7 [/SUP], Natalie So[SUP] 1 8 [/SUP], Wenhao O Ouyang[SUP] 1 [/SUP], Ian A Wilson[SUP] 4 9 [/SUP], Tom Gallagher[SUP] 10 [/SUP], Stanley Perlman[SUP] 11 12 [/SUP], Nicholas C Wu[SUP] 13 14 15 16 [/SUP], Lok-Yin Roy Wong[SUP] 17 18 19 [/SUP]



Affiliations
Abstract

The fusion peptide of SARS-CoV-2 spike protein is functionally important for membrane fusion during virus entry and is part of a broadly neutralizing epitope. However, sequence determinants at the fusion peptide and its adjacent regions for pathogenicity and antigenicity remain elusive. In this study, we perform a series of deep mutational scanning (DMS) experiments on an S2 region spanning the fusion peptide of authentic SARS-CoV-2 in different cell lines and in the presence of broadly neutralizing antibodies. We identify mutations at residue 813 of the spike protein that reduced TMPRSS2-mediated entry with decreased virulence. In addition, we show that an F823Y mutation, present in bat betacoronavirus HKU9 spike protein, confers resistance to broadly neutralizing antibodies. Our findings provide mechanistic insights into SARS-CoV-2 pathogenicity and also highlight a potential challenge in developing broadly protective S2-based coronavirus vaccines.


 
Back
Top Bottom